Detalhe da pesquisa
1.
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
J Antimicrob Chemother;
76(12): 3286-3295, 2021 11 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34450619
2.
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
Trials;
22(1): 487, 2021 Jul 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34311777
3.
The Brain Basis for Misophonia.
Curr Biol;
27(4): 527-533, 2017 02 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28162895